stars 1 stars 2 stars 3

Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to initiate, optimize, and manage collaborations across industry and academia. In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry. The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma,biotech, and academia with solutions toshowcaseinnovations and technologies;finduntapped science;identifynew partners;acceleratedeal-making; andmanagecollaborations. Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the righttime for the purpose ofbringingscience to the marketfaster.

Inpart Questions

The Inpart annual revenue was $5.5 million in 2026.

Gilles Toulemonde is the CEO, co-founder of Inpart.

107 people are employed at Inpart.

Top Inpart Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users